1. Home
  2. ALDX vs COPL Comparison

ALDX vs COPL Comparison

Compare ALDX & COPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • COPL
  • Stock Information
  • Founded
  • ALDX 2004
  • COPL 2024
  • Country
  • ALDX United States
  • COPL Hong Kong
  • Employees
  • ALDX N/A
  • COPL N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • COPL
  • Sector
  • ALDX Health Care
  • COPL
  • Exchange
  • ALDX Nasdaq
  • COPL NYSE
  • Market Cap
  • ALDX 270.7M
  • COPL 238.0M
  • IPO Year
  • ALDX 2014
  • COPL 2025
  • Fundamental
  • Price
  • ALDX $4.81
  • COPL $10.09
  • Analyst Decision
  • ALDX Strong Buy
  • COPL
  • Analyst Count
  • ALDX 2
  • COPL 0
  • Target Price
  • ALDX $9.50
  • COPL N/A
  • AVG Volume (30 Days)
  • ALDX 1.2M
  • COPL 363.0
  • Earning Date
  • ALDX 08-12-2025
  • COPL 01-01-0001
  • Dividend Yield
  • ALDX N/A
  • COPL N/A
  • EPS Growth
  • ALDX N/A
  • COPL N/A
  • EPS
  • ALDX N/A
  • COPL N/A
  • Revenue
  • ALDX N/A
  • COPL N/A
  • Revenue This Year
  • ALDX N/A
  • COPL N/A
  • Revenue Next Year
  • ALDX $29.89
  • COPL N/A
  • P/E Ratio
  • ALDX N/A
  • COPL N/A
  • Revenue Growth
  • ALDX N/A
  • COPL N/A
  • 52 Week Low
  • ALDX $1.14
  • COPL $10.00
  • 52 Week High
  • ALDX $7.20
  • COPL $10.22
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 53.97
  • COPL N/A
  • Support Level
  • ALDX $5.21
  • COPL N/A
  • Resistance Level
  • ALDX $5.35
  • COPL N/A
  • Average True Range (ATR)
  • ALDX 0.33
  • COPL 0.00
  • MACD
  • ALDX -0.12
  • COPL 0.00
  • Stochastic Oscillator
  • ALDX 40.70
  • COPL 0.00

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About COPL COPLEY ACQUISITION CORP

Copley Acquisition Corp is a blank check company.

Share on Social Networks: